Learn more about acute lymphoblastic leukemia, including its symptoms, what causes and how we treat it.
Retinoblastoma is a rare cancer of the retina (the innermost layer of the eye, located at the back of the eye, that receives light and images necessary for vision).
Leukemia is the most common form of pediatric cancer. It affects approximately 3,250 children each year in the US, accounting for about 30 percent of childhood cancers. It can occur at any age, although it is most commonly seen in children between 2 and 6 years of age.
Rhabdomyosarcoma is a cancerous tumor that originates in the soft tissues of the body, including the muscles, tendons, and connective tissues.
Soft tissue sarcoma is a type of cancer that grows in soft tissues that support and connect parts of the body.
Skin cancer is a malignant tumor that grows in the skin cells.
Neuroblastoma is a cancerous tumor that begins in nerve tissue of infants and very young children.
Brain tumors are the most common solid tumors in children.
Germ cell tumors are malignant (cancerous) or nonmalignant (benign, noncancerous) tumors that are comprised mostly of germ cells.
NHL is cancer in the lymphatic system. The lymphatic system is part of the immune system and functions to fight disease and infections.
Our cancer team specializes in treating rare cancers like nasopharyngeal carcinoma. Learn more about its causes and treatments
Orthopaedists at Children’s National offer world-renowned expertise and life-changing care, including surgery, for children at high risk for bone fracture.
We deliver comprehensive care for all blood cancers including chemotherapy, bone marrow transplant and experimental therapeutics.
Our Brain Tumor Institute uses a unique approach, tapping in to the expertise of both neurologists and neuro-oncologists, to deliver the best possible care.
Our oncology (cancer) team provides personalized treatment plans for children with cancer, including access to clinical trials.
Our Solid Tumor Program has a dedicated team of sarcoma experts who specialize in the newest treatments and clinical trials.